STAT

STAT Plus: Pharmalittle: AstraZeneca could profit from Covid-19 vaccine as of July; New England Journal slams Trump

AstraZeneca could start profiting from its Covid-19 vaccine as soon as July 2021, according to a memo showing the drug maker can declare when it considers the pandemic over.
Source: Alex Hogan/STAT

Top of the morning to you, and a fine one, it is. Once again, clear blue skies and deliciously cool breezes are enveloping

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanofi Licensing Novavax’s Covid Shot, Moderna’s RSV Vaccine, And More
Sanofi said it has reached a licensing deal to sell Novavax’s Covid shot as well as to try to combine the vaccine with Sanofi’s own flu vaccine.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks